Source: Eur Respir J, 55 (4) 1902262; 10.1183/13993003.02262-2019
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Elana J. Bernstein, John H.M. Austin, Steven M. Kawut, Ganesh Raghu, Eric A. Hoffman, John D. Newell, Jubal R. Watts, P. Hrudaya Nath, Sushilkumar K. Sonavane, R. Graham Barr, David J. Lederer. Antinuclear antibodies and subclinical interstitial lung disease in community-dwelling adults: the MESA study. Eur Respir J, 55 (4) 1902262; 10.1183/13993003.02262-2019

Member's Comments

No comment yet.

Related content which might interest you: Antacid use and subclinical interstitial lung disease: the MESA study Source: Eur Respir J, 49 (5) 1602566; 10.1183/13993003.02566-2016 Year: 2017 Antinuclear antibodies in interstitial lung diseases: Prevalence and predictive factors Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Interstitial lung disease associated with ANCA positivity: a retrospective analysis Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Prospective cohort study of the alternate healthy eating index-2010 and risk of chronic obstructive pulmonary disease in US women and men Source: Annual Congress 2013 –Environment and lifestyle: associations with respiratory disease Year: 2013 Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Long-term outcome of 53 patients with anti-Jo-1 antibody-positive interstitial lung disease Source: International Congress 2017 – Rare diseases Year: 2017 Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD) Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Sarcopenia in older people with chronic airway diseases: the Rotterdam study Source: ERJ Open Res, 7 (1) 00522-2020; 10.1183/23120541.00522-2020 Year: 2021 LATE-BREAKING ABSTRACT: Cardiovascular outcomes in community-dwelling older adults with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 Prevalence and incidence of chronic cough in middle-aged and older subjects: The Rotterdam Study Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 Incidence, prevalence and mortality of rheumatoid arthritis-associated interstitial lung disease : a retrospective study Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 Association between chronic obstructive pulmonary disease and endometriosis: a population-based cohort study Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020 Cardiovascular comorbidity in Danish patients with scleroderma-associated interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Prevalence of pulmonary involvement in rheumatoid arthritis patients in Indian population Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Underweight and weight loss are assocaited with greater mortality from chronic obstructive pulmonary disease (COPD) in middle-aged Japanese: The JACC study Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Respiratory symptoms and CRP among participants of the English longitudinal study of ageing (ELSA) – ageing or occult disease? Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Antinuclear autoantibodies (ANA) and C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Multicentric Latin American study of 211 patients with Interstitial lung disease and myositis related antibodies Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 Subclinical cardiovascular disease in early emphysema. The MESA Lung Study Source: Annual Congress 2008 - Outcome and trends in obstructive lung disease (OLD) and cardiovascular relation to OLD Year: 2008